MIMEDX GROUP INC - COMMON STOCK
7.1300
06-May-24 15:59:58
15 minutes delayed
Stocks
-0.2400
-3.26%
Today's range
7.0850 - 7.4250
ISIN
N/A
Source
NASDAQ
-
MIMEDX Announces Chief Financial Officer Transition
23 Mar 2023 16:01:00 By Nasdaq GlobeNewswire
-
MIMEDX Comments on Recent Data Brief Published by Office of Inspector General
16 Mar 2023 08:00:01 By Nasdaq GlobeNewswire
-
MIMEDX Announces Fourth Quarter and Full Year 2022 Operating and Financial Results
28 Feb 2023 16:01:01 By Nasdaq GlobeNewswire
-
15 Feb 2023 08:00:00 By Nasdaq GlobeNewswire
-
MIMEDX Appoints Joseph H. Capper as Chief Executive Officer and Director
30 Jan 2023 08:00:01 By Nasdaq GlobeNewswire
-
09 Jan 2023 08:03:58 By Nasdaq GlobeNewswire
-
04 Jan 2023 16:01:00 By Nasdaq GlobeNewswire
-
MIMEDX Appoints Ricci S. Whitlow as Chief Operating Officer
03 Jan 2023 08:00:01 By Nasdaq GlobeNewswire
-
08 Dec 2022 08:00:01 By Nasdaq GlobeNewswire
-
MIMEDX to Present at Upcoming Investor Conferences
10 Nov 2022 08:00:02 By Nasdaq GlobeNewswire
-
MIMEDX Announces Third Quarter 2022 Operating and Financial Results
02 Nov 2022 16:15:01 By Nasdaq GlobeNewswire
-
MIMEDX to Host Third Quarter 2022 Operating and Financial Results Conference Call on November 2
19 Oct 2022 08:00:01 By Nasdaq GlobeNewswire
-
MIMEDX Appoints Matt Notarianni as Head of Investor Relations
04 Oct 2022 08:00:01 By Nasdaq GlobeNewswire
-
MIMEDX Announces Launch of AXIOFILL™
20 Sep 2022 08:00:02 By Nasdaq GlobeNewswire
-
MIMEDX Announces Launch of AMNIOEFFECT™
19 Sep 2022 07:00:00 By Nasdaq GlobeNewswire
-
MIMEDX EPIFIX® Receives Reimbursement Approval in Japan
12 Sep 2022 16:30:00 By Nasdaq GlobeNewswire
-
MIMEDX Announces Leadership Transition
06 Sep 2022 07:00:00 By Nasdaq GlobeNewswire
-
26 Aug 2022 09:00:00 By Nasdaq GlobeNewswire
-
MIMEDX to Present at the Canaccord Genuity 42nd Annual Growth Conference
04 Aug 2022 16:08:43 By Nasdaq GlobeNewswire
-
MIMEDX Announces Second Quarter 2022 Operating and Financial Results
02 Aug 2022 16:07:16 By Nasdaq GlobeNewswire